Different Models of Tracheal Catheters Are Used for Female Thyroid Glands

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-65
SponsorAnqing Municipal Hospital

About this trial

Objective:Compare whether the use of tracheal catheters of models 6.0 and 6.5 causes less sore throat in women after thyroid surgery compared with the traditional use of model 7.0 tracheal catheters.Methods: Investigators enrolled 180 female patients with American Society of Anesthesiologists (ASA) physical status I and III, aged 18-65 years, and scheduled for elective undergoing thyroid surgery with general anesthesia. The participants were randomly assigned into three groups(n=60 each group):Group A: Tracheal catheter group with an inner diameter of 6.0mm, Group B: Tracheal catheter group with an inner diameter of 6.5mm, Group C: Tracheal catheter group with an inner diameter of 7.0mm.The incidence and severity of postoperative sore throat were recorded in three groups at 1 h, 6 h, 24 h and 48 h after operation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female;

Thyroid surgery should be performed under general anesthesia (GA) at an appropriate time;

ASA grade I-III;

Aged 18-65 years;

Disqualifiers

Reflux esophagitis, preoperative sore throat, chronic pharyngitis, preoperative hoarseness, use of anticoagulants or corticosteroids, high risk of reflux or aspiration, dysphagia, previous oral or pharyngeal surgical intervention, bleeding disorder, severe heart, lung, liver and kidney dysfunction

Upper respiratory tract infection occurred within 2 weeks before surgery

Unable to insert ET (no more than two intubations)

Patients with hoarseness or sore throat before surgery

Trial population

Healthy female thyroid surgery patients, ages 18-65 years, did not have serious systemic disease

Trial design

Design model

Case-control

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

180 Participants
are grouped into 3 trial groups
Group A: 6.0#
Group B: 6.5#
Group C: 7.0#

Trial outcomes

Primary outcomes

1

The incidence of postoperative sore throat

The incidence of postoperative sore throat

Time frame
at 1 hour, 6 hour, 24 hour and 48 hour after operation

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.